-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Johnson & Johnson, Lowers Price Target to $280

Benzinga·10/14/2026 13:37:02
RBC Capital analyst Trung Huynh maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $290 to $280.